Musculoskeletal Tumors Unit
What does the Unit treat?
The Musculoskeletal Tumors Unit of HM CIOCC is a national reference, specialized in the treatment of leiomyosarcoma, liposarcoma, and other less common subtypes of sarcomas.
At HM Hospitals (CIOCC), the Musculoskeletal Tumors Unit focuses on:
- Development of innovative clinical trials for patients with leiomyosarcoma, liposarcoma, or other less common subtypes of sarcomas, both in localized situations and in metastatic disease.
Related Diseases
- Mesothelioma.
- Sarcoma.
- Ewing’s Sarcoma.
Who is this Unit for?
The Musculoskeletal Tumors Unit is aimed at:
- Patients with leiomyosarcoma, liposarcoma, or other less common subtypes of sarcomas.
- Patients seeking to participate in innovative clinical trials.
- Family members and caregivers seeking information and support for their loved ones with sarcomas.
- Healthcare professionals who wish to refer patients for specialized sarcoma evaluation and treatment.
How do we approach it at HM Hospitals?
Surgery
We aim to remove as much of the tumor as possible, preserving the function of the reproductive organs to the maximum extent.
Chemotherapy
We use state-of-the-art medications to reach and destroy cancer cells that may be present anywhere in the body.
Radiotherapy
We direct high-energy beams to destroy cancer cells, minimizing damage to surrounding healthy tissues.
Targeted therapies
They act on specific molecular targets of cancer cells, selectively disrupting their growth and spread.
Immunotherapy
Through drugs, we stimulate the patient’s immune system to naturally recognize and attack cancer cells.